Navigation Links
Recent Study Demonstrates Anti-Inflammatory Properties of Oligonol® Lychee Fruit Polyphenols in Humans

PURCHASE, N.Y., Feb. 14, 2011 /PRNewswire/ -- A recently published study in Nutrition Research and Practice (Nutr Res Pract 2010;4(3):203-207) has verified the anti-inflammatory effects in humans of Oligonol® lychee fruit polyphenol.  The study examined Oligonol intake on cortisol and related cytokines in healthy young men.  Both cortisol and cytokine concentrations are inflammatory markers known to increase when stress such as exercise is caused on the body.  This study showed that oral intake of Oligonol had a significant effect on inhibiting cortisol and key inflammatory markers.

"Although a number of studies have demonstrated the anti-oxidant and anti-inflammatory properties of Oligonol, this is the first published trial in humans that confirms a important role for Oligonol as an anti-inflammatory agent," said Dr. Dan Kenner, a leading writer and consultant in alternative health care.

The study investigated Oligonol intake on cortisol, interleukin (IL)-1beta and IL-6 concentrations at rest and after physical exercise in nineteen healthy, sedentary males.  Each individual received water with 100 mg of Oligonol twice daily or a placebo for four weeks.  The body composition, the white blood cell and differential counts as well as the serum cortisol, interleukin (IL)-1beta and IL-6 concentration were measured before and after Oligonol intake.  The results showed that intake of Oligonol significantly decreased levels of cortisol and serum levels of IL-1beta and IL-6 compared to before treatment.  

Initiated four weeks prior in the first phase of the study, the individuals did not exercise but received the same dose of Oligonol or placebo.  Although not as significant, the results also demonstrated a reduction of the stress hormones cortisol and inflammatory cytokines (IL-1beta and IL-6).

"Flavanols from polyphenols are one of the most exciting and important topics in nutrition research in 2011, and results from this study provide further suggestions about the potential value of flavanol supplementation for health and human performance," said Dr. Robert Hackman, research professor at the University of California.

Oligonol is a unique, proprietary form of lychee fruit extract with significantly improved bioavailability due to its low-molecular weight polyphenols.  With a polyphenol concentration second only to strawberry, lychee fruit is a potent antioxidant that has proven beneficial for a number of health conditions. Clinical studies with Oligonol have demonstrated benefits for skin health through improving blood flow to the subdermal layer protecting it from damage caused by UV light and free radicals.  Other studies with Oligonol have shown improved cardiovascular function, reduction of visceral fat as well as reduction of exercise fatigue.  Oligonol has been successfully marketed in Japan as a functional ingredient for supplements, cosmetics and food.  Oligonol has been accepted as a "New Dietary Ingredient" by the FDA, received the prestigious Nutracon award as the Top Evidence-based New Ingredient of 2008 and has attained self-affirmed GRAS status.

SOURCE Maypro Industries
Copyright©2010 PR Newswire.
All rights reserved

Related medicine technology :

1. CareCentrix to Present at Hospital Readmissions Conference
2. Rochester Medical Reports First Quarter Results and Recent Developments
3. Webcast Alert: Isis Pharmaceuticals Holds Webcast to Discuss Recent Advances in its Development Pipeline
4. European Neurologists Expect Significant Increases in the Use of Both Tysabri and Extavia in Their Multiple Sclerosis Patients the Next Six Months, According to a Recent Report From BioTrends
5. Recent NDRC Pricing Concessions Not Expected to Impact China Sky Ones Portfolio of Products
6. Arena Pharmaceuticals Announces Third Quarter 2010 Financial Results and Reviews Recent Developments
7. Recent Patient Series Demonstrates Spirus Medicals Power Spiral Endoscope Enables Unprecedented Access to GI Tract
8. CareCentrix Appoints Chief Information Officer
9. Argos Therapeutics to Present Recent Clinical Developments and Corporate Overview at 18th Annual BioPartnering Europe
10. Lingohocken Fire Company Receives PAD Donation After Recent Rescue at Fox Heath Farm
11. Study of Brands Shows Tylenol Maintains Consumer Loyalty Despite Recent Quality Challenges
Post Your Comments:
(Date:11/25/2015)... issue of United States patent No. 9,192,509  entitled: " Methods and Apparatus ... AVACEN 100 dry heat therapy medical device and specific methods of use, referred to by the ... - ... ... ...
(Date:11/25/2015)... Israel , November 25, 2015 ... "New Investors"), pursuant to which BioLight and the New ... IOPtima Ltd. subsidiary ("IOPtima") via a private placement. The ... of its innovative IOPtimate™ system used in the treatment ... approval pathway process for the IOPtimate™ system with the ...
(Date:11/25/2015)... November 25, 2015 --> ... sie eine Lizenz für das Patent über eine neue ... und ENS-Lyon innehaben, an Enyo Pharma vergeben haben. ... ins Leben gerufenen und von Edelris gemeinsam mit seinen ... ein Behandlungsziel für HBV identifiziert, und es wurden neue ...
Breaking Medicine Technology:
(Date:11/24/2015)... ... November 25, 2015 , ... ... Their Care Plan software creates an agreement between the practice owner and ... including financial, scheduling, monitoring, notification, and projections. Click here to ...
(Date:11/24/2015)... ... November 24, 2015 , ... Charitable giving is at its peak during ... the last five weeks of the year totalling over $358 billion in 2014. ... the nation’s charities with those individuals who want to “give back” during the holidays. ...
(Date:11/24/2015)... ... 2015 , ... The hospitals and health systems on this ... care. They have received recognition for excellence from various reputable organizations in areas ... Hospital Review selected hospitals for inclusion based on national rankings and awards from ...
(Date:11/24/2015)... ... 2015 , ... In response to recent news highlighting Oxycodone fraud, Novus Medical ... the United States grew 400 percent between 1999 and 2010, far more than the ... percent of all fatal drug overdoses. (1) , While oxycodone and the extended release ...
(Date:11/24/2015)... ... , ... Serenity Point Rehabilitation, a holistic treatment center for substance abuse located ... the staff members at their recovery center. The videos highlight some of the various ... the things that make their recovery program so unique. , “Making the decision to ...
Breaking Medicine News(10 mins):